gefitinib has been researched along with ag 1879 in 5 studies
Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (ag 1879) | Trials (ag 1879) | Recent Studies (post-2010) (ag 1879) |
---|---|---|---|---|---|
5,231 | 566 | 2,919 | 575 | 0 | 215 |
Protein | Taxonomy | gefitinib (IC50) | ag 1879 (IC50) |
---|---|---|---|
Chain A, Lck Kinase | Homo sapiens (human) | 0.02 | |
Chain A, Tyrosine-protein kinase Lyn | Mus musculus (house mouse) | 0.009 | |
Chain A, Tyrosine-protein kinase Lyn | Mus musculus (house mouse) | 0.009 | |
Receptor-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | 0.019 | |
Proto-oncogene tyrosine-protein kinase Src | Gallus gallus (chicken) | 0.036 | |
Epidermal growth factor receptor | Homo sapiens (human) | 0.48 | |
Tyrosine-protein kinase Lck | Homo sapiens (human) | 0.004 | |
Proto-oncogene tyrosine-protein kinase LCK | Mus musculus (house mouse) | 0.031 | |
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 0.0052 | |
Tyrosine-protein kinase Lyn | Homo sapiens (human) | 0.0005 | |
Tyrosine-protein kinase HCK | Homo sapiens (human) | 0.005 | |
Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | 1.1814 | |
Tyrosine-protein kinase CSK | Homo sapiens (human) | 0.5 | |
Casein kinase I isoform delta | Homo sapiens (human) | 0.041 | |
Mitogen-activated protein kinase 14 | Homo sapiens (human) | 4.23 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB | 1 |
Chen, YR; Cheng, HH; Fu, YN; Huang, SF; Tsai, SF; Yang, CH; Yeh, CL | 1 |
Jeong, YJ; Kim, CH; Kim, DJ; Kim, JC; Lee, KB; Oh, SM; Park, JH | 1 |
Jensen, RT; Moody, TW; Moreno, P; Nuche-Berenguer, B | 1 |
5 other study(ies) available for gefitinib and ag 1879
Article | Year |
---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |
Navigating the kinome.
Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology | 2011 |
EGFR mutants found in non-small cell lung cancer show different levels of sensitivity to suppression of Src: implications in targeting therapy.
Topics: Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Survival; Drug Resistance, Neoplasm; ErbB Receptors; Exons; Gefitinib; Humans; Immunoprecipitation; Lung Neoplasms; Phosphorylation; Point Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins pp60(c-src); Pyrimidines; Quinazolines; Sequence Deletion; Tyrosine | 2008 |
RIP2/RICK-dependent cytokine production upon Yersinia enterocolitica infection in macrophages with TLR4 deficiency.
Topics: Animals; Enzyme Inhibitors; Gefitinib; Imidazoles; Interleukin-10; Interleukin-6; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Nod1 Signaling Adaptor Protein; Nod2 Signaling Adaptor Protein; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Quinazolines; Receptor-Interacting Protein Serine-Threonine Kinase 2; Receptor-Interacting Protein Serine-Threonine Kinases; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Yersinia enterocolitica; Yersinia Infections | 2013 |
CI-988 Inhibits EGFR Transactivation and Proliferation Caused by Addition of CCK/Gastrin to Lung Cancer Cells.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dipeptides; ErbB Receptors; Gastrins; Gefitinib; Hormone Antagonists; Humans; Indoles; Lung Neoplasms; Meglumine; Pyrimidines; Quinazolines | 2015 |